US 8247564
Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity
granted A61KA61K31/439A61K31/445
Quick answer
US patent 8247564 (Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity) held by Theravance, Inc. expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/439, A61K31/445, A61K31/4545, A61P